Quantitative abnormalities |
Congenital |
Afibrinogenemia (uncommon, autosomal recessive) |
Hypofibrinogenemia (autosomal dominant) |
Acquired |
Hypofibrinogenemia (eg, liver disease, plasma exchange therapy, consumptive coagulopathies such as DIC, hemophagocytic lymphohistiocytosis [HLH]) |
Hyperfibrinogenemia (eg, inflammation, neoplasia, pregnancy) |
Medications (eg, fibrinolytic agents, isotretinoin, L-asparaginase, tigecycline, valproic acid) |
Qualitative abnormalities |
Congenital |
Dysfibrinogenemia (autosomal dominant) |
Hypodysfibrinogenemia (autosomal dominant) |
Acquired |
Liver disease |
Malignancies (eg, renal carcinoma, hepatoma, multiple myeloma) |
Antifibrinogen antibodies |
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟